{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:05:02Z","timestamp":1792623902008,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":4051,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Canine osteosarcoma (OS) is associated with localized pain as a result of tissue injury from tumor infiltration and peritumoral inflammation. Malignant bone pain is caused by stimulation of peripheral pain receptors, termed nociceptors, which reside in the localized tumor microenvironment, including the periosteal and intramedullary bone cavities. Several nociceptive ligands have been determined to participate directly or indirectly in generating bone pain associated with diverse skeletal abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Canine OS cells actively produce nociceptive ligands with the capacity to directly or indirectly activate peripheral pain receptors residing in the bone tumor microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Ten dogs with appendicular OS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Expression of nerve growth factor, endothelin-1, and microsomal prostaglandin E synthase-1 was characterized in OS cell lines and naturally occurring OS samples. In 10 dogs with OS, circulating concentrations of nociceptive ligands were quantified and correlated with subjective pain scores and tumor volume in patients treated with standardized palliative therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Canine OS cells express and secrete nerve growth factor, endothelin-1, and prostaglandin E2. Naturally occurring OS samples uniformly express nociceptive ligands. In a subset of OS-bearing dogs, circulating nociceptive ligand concentrations were detectable but failed to correlate with pain status. Localized foci of nerve terminal proliferation were identified in a minority of primary bone tumor samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Canine OS cells express nociceptive ligands, potentially permitting active participation of OS cells in the generation of malignant bone pain. Specific inhibitors of nociceptive ligand signaling pathways might improve pain control in dogs with OS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.12511","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T12:46:24Z","timestamp":1420721184000},"page":"268-275","source":"Crossref","is-referenced-by-count":19,"title":["Expression of Nociceptive Ligands in Canine Osteosarcoma"],"prefix":"10.1093","volume":"29","author":[{"given":"S.","family":"Shor","sequence":"first","affiliation":[{"name":"University of Illinois Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Fadl-Alla","sequence":"additional","affiliation":[{"name":"University of Illinois Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Pondenis","sequence":"additional","affiliation":[{"name":"University of Illinois Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[{"name":"University of Illinois Department of Pathobiology, , Urbana, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Wycislo","sequence":"additional","affiliation":[{"name":"University of Illinois Department of Pathobiology, , Urbana, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lezmi","sequence":"additional","affiliation":[{"name":"University of Illinois Department of Pathobiology, , Urbana, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.M.","family":"Fan","sequence":"additional","affiliation":[{"name":"University of Illinois Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,1]]},"reference":[{"key":"2026020304424966200_jvim12511-bib-0001","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2044.1978.tb08326.x","article-title":"Pain pathways and mechanisms","volume":"33","author":"Bowsher","year":"1978","journal-title":"Anaesthesia"},{"key":"2026020304424966200_jvim12511-bib-0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(98)00048-3","article-title":"The induction of pain: An integrative review","volume":"57","author":"Millan","year":"1999","journal-title":"Prog Neurobiol"},{"key":"2026020304424966200_jvim12511-bib-0003","first-page":"S93","article-title":"The changing sensitivity in the life of the nociceptor","volume-title":"Pain","author":"Koltzenburg","year":"1999"},{"key":"2026020304424966200_jvim12511-bib-0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/02599148709166229","article-title":"Pain control in terminal cancer","volume":"9","author":"Sykes","year":"1987","journal-title":"Int Disabil Stud"},{"key":"2026020304424966200_jvim12511-bib-0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(02)00165-3","article-title":"Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur","volume":"113","author":"Mach","year":"2002","journal-title":"Neuroscience"},{"key":"2026020304424966200_jvim12511-bib-0006","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1749-6632.2010.05389.x","article-title":"Transient receptor potential vanilloid 4: The sixth sense of the musculoskeletal system?","volume":"1192","author":"Guilak","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2026020304424966200_jvim12511-bib-0007","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/cncr.11144","article-title":"Bone cancer pain","volume":"97","author":"Clohisy","year":"2003","journal-title":"Cancer"},{"key":"2026020304424966200_jvim12511-bib-0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.npep.2007.12.001","article-title":"Endothelin-1-induced pain and hyperalgesia: A review of pathophysiology, clinical manifestations and future therapeutic options","volume":"42","author":"Hans","year":"2008","journal-title":"Neuropeptides"},{"key":"2026020304424966200_jvim12511-bib-0009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1749-6632.1998.tb09567.x","article-title":"Pain modulatory actions of cytokines and prostaglandin E2 in the brain","volume":"840","author":"Hori","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"2026020304424966200_jvim12511-bib-0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0166-2236(93)90092-Z","article-title":"Nerve growth factor and nociception","volume":"16","author":"Lewin","year":"1993","journal-title":"Trends Neurosci"},{"key":"2026020304424966200_jvim12511-bib-0011","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0024-3205(00)00705-0","article-title":"Anti-apoptotic action of nerve growth factor in mouse osteoblastic cell line","volume":"67","author":"Mogi","year":"2000","journal-title":"Life Sci"},{"key":"2026020304424966200_jvim12511-bib-0012","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S8756-3282(03)00215-1","article-title":"Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures","volume":"33","author":"von Schroeder","year":"2003","journal-title":"Bone"},{"key":"2026020304424966200_jvim12511-bib-0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0952-3278(94)90140-6","article-title":"Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1","volume":"50","author":"Igarashi","year":"1994","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2026020304424966200_jvim12511-bib-0014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0300985813505879","article-title":"When tissue antigens and\u00a0antibodies get along: Revisiting the technical aspects of immunohistochemistry\u2014The red, brown, and blue technique","volume":"51","author":"Ramos-Vara","year":"2014","journal-title":"Vet Pathol"},{"key":"2026020304424966200_jvim12511-bib-0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3415\/VCOT-10-04-0051","article-title":"Nerve growth factor concentrations in the synovial fluid from healthy dogs and dogs with secondary osteoarthritis","volume":"24","author":"Isola","year":"2011","journal-title":"Vet Comp Orthop Traumatol"},{"key":"2026020304424966200_jvim12511-bib-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/plef.2000.0231","article-title":"Prostaglandin E2 concentrations in naturally occurring canine cancer","volume":"64","author":"Mohammed","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2026020304424966200_jvim12511-bib-0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2014.01.002","article-title":"Serum big endothelin-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs","volume-title":"Life Sci","author":"Fukumoto","year":"2014"},{"key":"2026020304424966200_jvim12511-bib-0018","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2460\/ajvr.2004.65.1634","article-title":"Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs","volume":"65","author":"Hudson","year":"2004","journal-title":"Am J Vet Res"},{"key":"2026020304424966200_jvim12511-bib-0019","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jvim.12121","article-title":"Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma","volume":"27","author":"Sternberg","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020304424966200_jvim12511-bib-0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tox.2013.03.012","article-title":"Chloroquine causes similar electroretinogram modifications, neuronal phospholipidosis and marked impairment of synaptic vesicle transport in albino and pigmented rats","volume":"308","author":"Lezmi","year":"2013","journal-title":"Toxicology"},{"key":"2026020304424966200_jvim12511-bib-0021","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.1158\/0008-5472.CAN-05-0826","article-title":"A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone","volume":"65","author":"Halvorson","year":"2005","journal-title":"Cancer Res"},{"key":"2026020304424966200_jvim12511-bib-0022","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2005.02.022","article-title":"Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization","volume":"115","author":"Sevcik","year":"2005","journal-title":"Pain"},{"key":"2026020304424966200_jvim12511-bib-0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1744-8069-6-87","article-title":"Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain","volume":"6","author":"Ghilardi","year":"2010","journal-title":"Mol Pain"},{"key":"2026020304424966200_jvim12511-bib-0024","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuroscience.2004.04.027","article-title":"Endothelin and the tumorigenic component of bone cancer pain","volume":"126","author":"Peters","year":"2004","journal-title":"Neuroscience"},{"key":"2026020304424966200_jvim12511-bib-0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2004.04.016","article-title":"Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain","volume":"492","author":"Yuyama","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"2026020304424966200_jvim12511-bib-0026","first-page":"561","article-title":"The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer pain","volume":"2","author":"Sabino","year":"2002","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2026020304424966200_jvim12511-bib-0027","first-page":"7343","article-title":"Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2","volume":"62","author":"Sabino","year":"2002","journal-title":"Cancer Res"},{"key":"2026020304424966200_jvim12511-bib-0028","doi-asserted-by":"crossref","first-page":"671386","DOI":"10.1155\/2012\/671386","article-title":"Effects of different electroacupuncture scheduling regimens on murine bone tumor-induced hyperalgesia: Sex differences and role of inflammation","volume":"2012","author":"Smeester","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"2026020304424966200_jvim12511-bib-0029","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.lfs.2011.02.008","article-title":"Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice","volume":"88","author":"Isono","year":"2011","journal-title":"Life Sci"},{"key":"2026020304424966200_jvim12511-bib-0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1601-0825.2010.01717.x","article-title":"Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients","volume":"17","author":"Jang","year":"2011","journal-title":"Oral Dis"},{"key":"2026020304424966200_jvim12511-bib-0031","doi-asserted-by":"crossref","first-page":"e44687","DOI":"10.1371\/journal.pone.0044687","article-title":"Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"2026020304424966200_jvim12511-bib-0032","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2842.2011.02271.x","article-title":"Human temporomandibular joint and myofascial pain biochemical profiles: A case-control study","volume":"39","author":"Basi","year":"2012","journal-title":"J Oral Rehabil"},{"key":"2026020304424966200_jvim12511-bib-0033","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1939-1676.1994.tb03232.x","article-title":"Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder","volume":"8","author":"Knapp","year":"1994","journal-title":"J Vet Intern Med"},{"key":"2026020304424966200_jvim12511-bib-0034","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1523\/JNEUROSCI.3300-10.2010","article-title":"Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain","volume":"30","author":"Jimenez-Andrade","year":"2010","journal-title":"J Neurosci"},{"key":"2026020304424966200_jvim12511-bib-0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuroscience.2010.08.056","article-title":"Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain","volume":"171","author":"Mantyh","year":"2010","journal-title":"Neuroscience"},{"key":"2026020304424966200_jvim12511-bib-0036","doi-asserted-by":"crossref","first-page":"6296s","DOI":"10.1158\/1078-0432.CCR-06-0929","article-title":"Targeting bone metastasis in prostate cancer with endothelin receptor antagonists","volume":"12","author":"Carducci","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2026020304424966200_jvim12511-bib-0037","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1464-410X.2010.09638.x","article-title":"Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: A double-blind, placebo-controlled, randomized Phase II trial","volume":"106","author":"James","year":"2010","journal-title":"BJU Int"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12511","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/29\/1\/268\/66688433\/jvim12511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/29\/1\/268\/66688433\/jvim12511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:42:56Z","timestamp":1770111776000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/29\/1\/268\/8452646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.12511","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,1]]},"published":{"date-parts":[[2015,1,1]]}}}